A lawsuit alleging that Johnson & Johnson’s Baby Powder and Shower-to-Shower products can contribute to the development of ovarian cancer has moved forward with a pool of 50 jurors having been selected for the litigation’s third trial.
The case is scheduled for trial and was put forward for a woman diagnosed with ovarian cancer in 2012, who was apparently an ongoing user of Johnson & Johnson talc-based powders.
According to Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products, “Our Firm is investing a number of cases that put forth similar allegations regarding Johnson & Johnson talcum powders and ovarian cancer. A great deal is a at stake for both plaintiffs and defendants involved in this litigation, so we will be monitoring the progress of this trial very closely.”
The case, which is one of around 1,800 talcum powder lawsuits filed against J&J in the US, comes after news last week that the company has requested that 18 federal lawsuits be relocated to New Jersey, its home state. It cited the reasons as being ‘most familiar with the issues’ and not as busy.